1104 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Immunogenicity in the Community Acquired Pneumonia Immunization Trial In Adults (CAPiTA)

Podobne knjige/članki

• 595 Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
  od: Bonten, Marc, et al.
  Izdano: (2014)
• Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults
  od: Isturiz, Raul, et al.
  Izdano: (2015)
• The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial
  od: Huijts, S.M., et al.
  Izdano: (2018)
• 1091 Serotype Distribution of S. pneumoniae Community Acquired Pneumonia (CAP) in Adults in the Netherlands in the CAPiTA (Community-Acquired Pneumonia Immunization Trial In Adults) Study Period
  od: Hollingsworth, Rosalind, et al.
  Izdano: (2014)
• 597 Increase in IPD incidence in Adults in 2013-2014 after 2 consecutive years of decline following introduction of 13-valent pneumococcal conjugate vaccine (PCV13)
  od: Baxter, Roger, et al.
  Izdano: (2014)